Investment Summary |
|
|---|---|
| Date | 2012-04-02 |
| Target | Research Organics |
| Sector | Life Science |
| Investor(s) | Sigma-Aldrich |
| Deal Type | Acquisition Financing |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1951 |
| Sector | Life Science |
| Employees | 9,800 |
| Revenue | 2.8B USD (2014) |
Sigma-Aldrich Corp. is a life science and high technology company whose biochemical, organic chemical products, kits, and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university, and government institutions, hospitals, and industry.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 13 |
| Sector: Life Science M&A | 8 of 10 |
| Type: Acquisition Financing M&A Deals | 1 of 1 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 8 of 9 |
| Year: 2012 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-31 |
BioReliance
Rockville, Maryland, United States BioReliance provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide. |
Buy | $350M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-11-04 |
Cell Marque
Rocklin, California, United States Cell Marque Corporation is a provider of in vitro diagnostic (IVD) antibody reagents and kits. |
Buy | - |
